Logo

Symyx Closes Deal to Buy MDL from Elsevier for $123M

Oct 03, 2007
NEW YORK (GenomeWeb News) - Symyx Technologies said yesterday that it has closed its $123 million all-cash purchase of Elsevier’s MDL Information Systems business.
 
Symyx said the final purchase price will be subject to "working capital and other adjustments."
 
The company also has set up a $25 million back-up line of credit for working capital and for future growth initiatives.
 
Symyx struck the agreement to buy MDL in August. At the time, it said it expected combined software and database operations to be around $100 million in 2008. At the time of the agreement, Symyx said MDL had around 1,000 customers and around 50,000 content and software users.
 
Symyx said this week that it expects to incur “significant restructuring and one-time acquisition costs" in the fourth quarter of 2007.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.